We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study on Immunopathogenesis in HIV and Hepatitis C Coinfection

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01296529
First Posted: February 15, 2011
Last Update Posted: December 12, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Ruth M. Rothstein CORE Center
Merck Sharp & Dohme Corp.
University of North Carolina, Chapel Hill
Information provided by (Responsible Party):
Gregory Huhn, Rush University Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Publications:
Hodowanec A, Brady KE, Gao W, Kincaid S, Plants J, Bahk M, Landay A, Huhn G. Differences in CD4+ T-cell Immune Activation in HIV, Hepatitis C (HCV), and HIV/HCV Coinfection Are Influenced by HIV and HCV Infection Status. Abstract MOPE011. 19th International AIDS Conference, Washington DC, July 23, 2012